Antiapoptotic activity of Stat5 required during terminal stages of myeloid differentiation

  1. Matthias Kieslinger1,
  2. Irina Woldman2,
  3. Richard Moriggl3,4,
  4. Johannes Hofmann1,
  5. Jean-Christophe Marine3,4,
  6. James N. Ihle3,4,
  7. Hartmut Beug1,5, and
  8. Thomas Decker2
  1. 1Institute of Molecular Pathology, Vienna Biocenter, A-1030 Vienna, Austria; 2Institute of Microbiology and Genetics, Vienna Biocenter, A-1030 Vienna, Austria; 3Howard Hughes Medical Institute and 4Department of Biochemistry, St. Jude Children's Research Hospital, Memphis, Tennessee 38105 USA

Abstract

Stat5 is activated by multiple receptors of hematopoietic cytokines. To study its role during hematopoiesis, we have generated primary chicken myeloblasts expressing different dominant-negative (dn) alleles of Stat5. This caused a striking inability to generate mature cells, due to massive apoptosis during differentiation. Bcl-2 was able to rescue differentiating cells expressing dnStat5 from apoptosis, suggesting that during cytokine-dependent differentiation the main function of the protein is to ensure cell survival. Our findings with dnStat5-expressing chicken myeloblasts were confirmed with primary hematopoietic cells from Stat5a/Stat5b-deficient mice. Bone marrow cells from these animals displayed a strong increase in apoptotic cell death during GM-CSF-dependent functional maturation in vitro. The antiapoptotic protein Bcl-x was induced by GM-CSF and IL-3 in a Stat5-dependent fashion. Ectopic expression of Bcl-x rescued Stat5-deficient bone marrow cells from apoptosis, indicating that Stat5 promotes the survival of myeloid progenitor cells through its ability to induce transcription of the bcl-x gene. Finally, the recruitment of myeloid cells to inflammatory sites was found strongly impeded in Stat5-deficient mice. Taken together, our findings suggest that Stat5 may promote cytokine-dependent survival and proliferation of differentiating myeloid progenitor cells in stress or pathological situations, such as inflammation.

Keywords

Footnotes

  • 5 Corresponding author.

  • E-MAIL beug{at}nt.imp.univie.ac.at; FAX 43-1-7989390.

    • Received June 11, 1999.
    • Accepted November 25, 1999.
| Table of Contents

Life Science Alliance